Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Zhang John Jing | 0001413696 | Feb-25-2010 | director |
HOU XIN WEN | 0001313138 | Dec-20-2004 | director, officer: Secretary |
XIAN RENFENG INVESTMENT LTD CO | 0001313140 | Dec-20-2004 | 10 percent owner |
TAO SAN DING | 0001313141 | Dec-20-2004 | officer: Chief Financial Officer |
WANG JING AN | 0001313142 | Dec-20-2004 | director, 10 percent owner, officer: Chief Executive Officer |
MALONE ARTHUR L JR | 0001047595 | Jun-01-2004 | director, officer: CEO |
ROBSON CRAIG | 0001253293 | Mar-17-2003 | director, 10 percent owner |
SALANOA ANASTASIA | 0001253294 | Dec-31-2002 | officer: Secretary |
RANNO CARL P | 0001109934 | May-30-2002 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Huifeng Bio-Pharmaceutical Technology, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
REVOKED | Document | Acc-no: 9999999997-13-000024 (34 Act) Size: 30 KB | Jan-03-2013 | 13504290 |
8-K | Document | Current report filing Acc-no: 0001144204-11-045915 (34 Act) Size: 21 KB |
Aug-12-2011 | 111029936 |
UPLOAD | Document | Acc-no: 0000000000-11-048801 ( Act) Size: 48 KB | Aug-11-2011 | |
UPLOAD | Document | Acc-no: 0000000000-11-044053 ( Act) Size: 57 KB | Jul-20-2011 | |
UPLOAD | Document | Acc-no: 0000000000-11-043234 ( Act) Size: 47 KB | Jul-18-2011 | |
8-K | Document | Current report filing Acc-no: 0001144204-11-040676 (34 Act) Size: 96 KB |
Jul-15-2011 | 11969020 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-11-036003 ( Act) Size: 11 KB |
Jun-16-2011 | |
UPLOAD | Document | Acc-no: 0000000000-11-034084 ( Act) Size: 45 KB | Jun-02-2011 | |
8-K | Document | Current report filing Acc-no: 0001144204-11-026263 (34 Act) Size: 20 KB |
May-05-2011 | 11812355 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-11-024184 ( Act) Size: 9 KB |
Apr-27-2011 | |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-11-020690 ( Act) Size: 8 KB |
Apr-07-2011 | |
NT 10-K | Document | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT Acc-no: 0001144204-11-018868 (34 Act) Size: 38 KB |
Mar-31-2011 | 11725263 |
UPLOAD | Document | Acc-no: 0000000000-11-018329 ( Act) Size: 53 KB | Mar-24-2011 | |
UPLOAD | Document | Acc-no: 0000000000-11-015200 ( Act) Size: 46 KB | Mar-10-2011 | |
8-K | Document | Current report filing Acc-no: 0001144204-11-013777 (34 Act) Size: 5236 KB |
Mar-09-2011 | 11675667 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-11-013710 ( Act) Size: 22 KB |
Mar-09-2011 | |
8-K/A | Document | Amendment to Current report filing Acc-no: 0001144204-11-013708 (34 Act) Size: 86 KB |
Mar-09-2011 | 11674623 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001144204-11-011564 ( Act) Size: 269 KB |
Feb-28-2011 | |
UPLOAD | Document | Acc-no: 0000000000-11-011692 ( Act) Size: 56 KB | Feb-23-2011 | |
8-K | Document | Current report filing Acc-no: 0001144204-11-009567 (34 Act) Size: 111 KB |
Feb-17-2011 | 11620821 |
Recent 20 filings. View all Huifeng Bio-Pharmaceutical Technology, Inc. filings
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
It's being easier working on the website. And I recommend, it's a great website
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by